Advertisement
Organisation › Details
Asabys Partners (ES)
Asabys Partners is a venture capital manager firm specialized in the healthcare sector, founded by Josep Ll. Sanfeliu and Clara Campàs and participated by Alantra. Its first investment vehicle, Sabadell Asabys Health Innovation Investments SCR, SA, was launched in 2019 and is backed by the Banc Sabadell as reference investor. The fund has a target size of more than €80M and invests in healthcare companies across three verticals: medtech, digital therapeutics and biotech, that have highly innovative and disruptive technologies. The fund’s investment in the company benefits from the financial backing of the European Union under the European Fund for Strategic Investments (“EFSI”) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing. *
Start | 2019-05-21 existent | |
Industry | venture capital | |
Industry 2 | LIFE SCIENCES | |
Person | Campàs Moya, Clara (Asabys Partners 201905 Founding Partner before Advancell S.A. 201504 Managing Director) | |
Person 2 | Sanfeliu, Josep Lluis (Asabys Partners 202103 Managing Partner + Co-Founder before Ysios Capital 201611) | |
Region | Spain_oo | |
Country | Spain (España) | |
City | n. a. | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: MedLumics. (2/10/21). "Press Release: MedLumics Closes Upsized EUR 18M (21.7M USD) Financing Round and Appoints New Chairman". Madrid. | ||
Record changed: 2023-06-22 |
Advertisement
More documents for Asabys Partners (ES)
- [1] Asabys Partners. (9/15/22). "Press Release: Asabys Launches a New €200m Fund to Invest in Biotech & Healthtech"....
- [2] Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona....
- [3] MedLumics. (2/10/21). "Press Release: MedLumics Closes Upsized EUR 18M (21.7M USD) Financing Round and Appoints New Chairman". Madrid....
- [4] IRB Barcelona. (5/21/19). "Press Release: The IRB Barcelona Spin-off Ona Therapeutics Hits the Road Thanks to Sabadell Asabys"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top